Alkan, AliYasar, ArzuToprak, Serhat2024-08-042024-08-0420201078-15521477-092Xhttps://doi.org/10.1177/1078155219835592https://hdl.handle.net/11616/98721Kaposi sarcoma (KS) is a low-grade mesenchymal angioproliferative disease, mostly observed in immune compromised patients. KS is mostly encountered in HIV-positive or organ transplant patients. The drugs causing immunosuppression have also been associated with KS. Here, we present a KS experience associated with rituximab-based therapy.eninfo:eu-repo/semantics/closedAccessRituximabKaposi sarcomalymphomaHHV-8Article2612202233085492610.1177/10781552198355922-s2.0-85062793902Q3WOS:000501268400028Q4